J.C. Wilson

Nov 12, 2024 | clinicalleader.com | Dan Schell |J.C. Wilson |Chris Manchester

Digging Through the Hype: Can AI/ML Assist Clinical Development? Join us on November 14th at 11:00am EST to learn approaches to leveraging AI and machine learning when handling clinical data, how to approach the use of Generative AI for analyzing clinical trial data, and how to approach human-in-the-loop data mapping with machine learning. Register here.

Aug 14, 2024 | clinicalleader.com | Harriet Gray Stephens |Edward Groleau |Dan Schell |J.C. Wilson

The Pros And Cons Of Synthetic Control Arms In Clinical TrialsExplore how synthetic control arms (SCAs) are being used in clinical trials, the views of regulators, and the advantages and limitations of SCAs in practice. Strengthening Pathways For Cell And Gene TherapiesThis report aims to spur informed discussions on the future trajectory of cell and gene therapies and their pivotal role in shaping the future of healthcare.

Jul 9, 2024 | wateronline.com | J.C. Wilson

By J.C. Wilson, Senior Director, Patient Centered Technologies Product & Engineering, IQVIA When sponsors and sites embrace decentralized clinical trial models, electronic clinical outcome assessments are among the first tools they adopt. These platforms automate the collection of the patient’s experiences through robust and reliable measures, providing real-time quantitative and qualitative insights.

May 16, 2023 | clinicalleader.com | J.C. Wilson

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client's selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its clients who have experienced the progressive degradation of today's outsourcing options.

Mar 4, 2023 | clinicalleader.com | J.C. Wilson

By J.C. Wilson, Senior Director, Patient Centered Technologies Product & Engineering, IQVIA When sponsors and sites embrace decentralized clinical trial models, electronic clinical outcome assessments are among the first tools they adopt. These platforms automate the collection of the patient’s experiences through robust and reliable measures, providing real-time quantitative and qualitative insights.